1.
Moraes R, Ferreira M, Vaz R, Coelho I, Pinheiro G, Gonçalves J, França M, Almeida I. Prevalence of Neuropsychiatric Adverse Effects in HIV Patients Treated with Dolutegravir. RPMI [Internet]. 2019 Mar. 15 [cited 2025 Jun. 2];26(1):14-20. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/357